156 related articles for article (PubMed ID: 31957836)
1. Effects of lncRNA SNHG20 on proliferation and apoptosis of non-small cell lung cancer cells through Wnt/β-catenin signaling pathway.
Wang ZX; Zhao Y; Yu Y; Liu N; Zou QX; Liang FH; Cheng KP; Lin FW
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):230-237. PubMed ID: 31957836
[TBL] [Abstract][Full Text] [Related]
2. LncRNA ASB16-AS1 promotes proliferation and inhibits apoptosis of non small cell lung cancer cells by activating the Wnt/β catenin signaling pathway.
Tan LJ; Liu JT; Yang M; Ju T; Zhang YS
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1870-1876. PubMed ID: 32141556
[TBL] [Abstract][Full Text] [Related]
3. Knockdown SNHG20 Suppresses Nonsmall Cell Lung Cancer Development by Repressing Proliferation, Migration and Invasion, and Inducing Apoptosis by Regulating miR-2467-3p/E2F3.
Chen H; Tan X; Ding Y
Cancer Biother Radiopharm; 2021 May; 36(4):360-370. PubMed ID: 32456448
[No Abstract] [Full Text] [Related]
4. SNHG20 knockdown suppresses proliferation, migration and invasion, and promotes apoptosis in non-small cell lung cancer through acting as a miR-154 sponge.
Lingling J; Xiangao J; Guiqing H; Jichan S; Feifei S; Haiyan Z
Biomed Pharmacother; 2019 Apr; 112():108648. PubMed ID: 30780105
[TBL] [Abstract][Full Text] [Related]
5. LncRNA-ATB promotes apoptosis of non-small cell lung cancer cells through MiR-200a/β-Catenin.
Wang T; Tang X; Liu Y
J BUON; 2019; 24(6):2280-2286. PubMed ID: 31983095
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of long non-coding RNA SNHG20 promotes ovarian cancer progression via Wnt/β-catenin signaling.
He S; Zhao Y; Wang X; Deng Y; Wan Z; Yao S; Shen H
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29101241
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SNHG20 enhances the progression of oral squamous cell carcinoma by regulating the miR-29a/DIXDC1/Wnt regulatory axis.
Chen ZF; Wang Y; Sun LL; Ding SY; Jinag H
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5436-5445. PubMed ID: 32495922
[TBL] [Abstract][Full Text] [Related]
8. LncRNA SNHG20 promoted proliferation, invasion and inhibited cell apoptosis of lung adenocarcinoma via sponging miR-342 and upregulating DDX49.
Wang X; Gu G; Zhu H; Lu S; Abuduwaili K; Liu C
Thorac Cancer; 2020 Dec; 11(12):3510-3520. PubMed ID: 33089952
[TBL] [Abstract][Full Text] [Related]
9. Influences of LncRNA SNHG20 on proliferation and apoptosis of glioma cells through regulating the PTEN/PI3K/AKT signaling pathway.
Guo LP; Zhang ZJ; Li RT; Li HY; Cui YQ
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):253-261. PubMed ID: 30657567
[TBL] [Abstract][Full Text] [Related]
10. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
[TBL] [Abstract][Full Text] [Related]
11. LncRNA-H19 inhibits apoptosis of acute myeloid leukemia cells via targeting miR-29a-3p.
Zhao TT; Liu X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):224-231. PubMed ID: 31389605
[TBL] [Abstract][Full Text] [Related]
12. Highly expressed long non-coding RNA FOXD2-AS1 promotes non-small cell lung cancer progression via Wnt/β-catenin signaling.
Rong L; Zhao R; Lu J
Biochem Biophys Res Commun; 2017 Mar; 484(3):586-591. PubMed ID: 28132805
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of HIF-2α-Dependent NEAT1 Promotes the Progression of Non-Small Cell Lung Cancer through miR-101-3p/SOX9/Wnt/β-Catenin Signal Pathway.
Kong X; Zhao Y; Li X; Tao Z; Hou M; Ma H
Cell Physiol Biochem; 2019; 52(3):368-381. PubMed ID: 30845377
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SNHG20 promoted the proliferation of glioma cells via sponging miR-4486 to regulate the MDM2-p53 pathway.
Liu J; Cheng LG; Li HG
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5323-5331. PubMed ID: 31298384
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA SNHG20 promotes bladder cancer via activating the Wnt/β-catenin signalling pathway.
Zhao Q; Gao S; Du Q; Liu Y
Int J Mol Med; 2018 Nov; 42(5):2839-2848. PubMed ID: 30106094
[TBL] [Abstract][Full Text] [Related]
16. LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer.
Yu DJ; Li YH; Zhong M
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4800-4806. PubMed ID: 31210311
[TBL] [Abstract][Full Text] [Related]
17. Effect of lncRNA-BLACAT1 on drug resistance of non-small cell lung cancer cells in DDP chemotherapy by regulating cyclin D1 expression.
Ju ZS; Sun B; Bao D; Zhang XF
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9465-9472. PubMed ID: 33015788
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of lncRNA XIST inhibits cell proliferation via regulating miR-744/RING1 axis in non-small cell lung cancer.
Wang J; Cai H; Dai Z; Wang G
Clin Sci (Lond); 2019 Jul; 133(14):1567-1579. PubMed ID: 31292221
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
[TBL] [Abstract][Full Text] [Related]
20. LncRNA SNHG20 knockdown suppresses the osteosarcoma tumorigenesis through the mitochondrial apoptosis pathway by miR-139/RUNX2 axis.
Wang W; Luo P; Guo W; Shi Y; Xu D; Zheng H; Jia L
Biochem Biophys Res Commun; 2018 Sep; 503(3):1927-1933. PubMed ID: 30072099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]